We are live on ! Find out more
CIBC Private Wealth Group

CIBC Private Wealth Group Portfolio holdings

AUM $59.2B
1-Year Est. Return 20.62%
This Fund
S&P 500
This Quarter Est. Return
-13.74%
1 Year Est. Return
+20.62%
3 Year Est. Return
+88.19%
5 Year Est. Return
+111.32%
10 Year Est. Return
+389.71%
AUM
$22.4B
AUM Growth
-$3.95B
Cap. Flow
-$83.7M
Cap. Flow %
-0.37%
Top 10 Hldgs %
21.03%
Holding
1,006
New
45
Increased
329
Reduced
394
Closed
141

Top Buys

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$420M
2
LIN icon
Linde
LIN
+$140M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$123M
4
CI icon
Cigna
CI
+$98.2M
5
ZTS icon
Zoetis
ZTS
+$90.5M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Healthcare 15.86%
3 Energy 14.48%
4 Financials 12.87%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRMD icon
851
CorMedix
CRMD
$617M
$77K ﹤0.01%
12,000
ECT
852
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$74K ﹤0.01%
+50,000
New +$90.2K
BCLI
853
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$53K ﹤0.01%
1,000
VUZI icon
854
Vuzix
VUZI
$190M
$48K ﹤0.01%
10,000
SNT
855
Senstar Technologies
SNT
$41.1M
$45K ﹤0.01%
10,000
PLM
856
DELISTED
PolyMet Mining Corp.
PLM
$40K ﹤0.01%
4,910
RMTI icon
857
Rockwell Medical
RMTI
$26.2M
$36K ﹤0.01%
143
DMK
858
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$34K ﹤0.01%
214
ZSAN
859
DELISTED
Zosano Pharma Corporation
ZSAN
$34K ﹤0.01%
457
-457
-50% -$57.9K
RAD
860
DELISTED
Rite Aid Corporation
RAD
$28K ﹤0.01%
2,000
NEOS
861
DELISTED
Neos Therapeutics, Inc
NEOS
$25K ﹤0.01%
15,335
PLX icon
862
Protalix BioTherapeutics
PLX
$191M
$8K ﹤0.01%
2,500
GMO
863
DELISTED
General Moly, Inc.
GMO
$3K ﹤0.01%
13,518
ESES
864
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
$1K ﹤0.01%
18,000
-76,000
-81% -$12K
ABEV icon
865
Ambev
ABEV
$47.3B
-36,400
Closed -$166K
AEO icon
866
American Eagle Outfitters
AEO
$2.85B
-21,089
Closed -$524K
ALKS icon
867
Alkermes
ALKS
$8.82B
-173,424
Closed -$7.36M
BNBX
868
DELISTED
BNB PLUS CORP
BNBX
0
-$60K
AWK icon
869
American Water Works
AWK
$26.3B
-10,918
Closed -$960K
BIO icon
870
Bio-Rad Laboratories Class A
BIO
$8.42B
-5,612
Closed -$1.76M
BLOK icon
871
Amplify Blockchain Technology ETF
BLOK
$1.1B
-34,715
Closed -$703K
BTI icon
872
British American Tobacco
BTI
$132B
-28,029
Closed -$1.31M
BWXT icon
873
BWX Technologies
BWXT
$16B
-299,431
Closed -$18.7M
CCS icon
874
Century Communities
CCS
$2B
-62,592
Closed -$1.64M
CE icon
875
Celanese
CE
$5.09B
-17,805
Closed -$2.03M

Similar funds

CIBC Private Wealth Group's Q4 2018 Portfolio in Review

As of Q4 2018, CIBC Private Wealth Group held 1,006 positions worth $22.4B, down 15% from $26.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

CIBC Private Wealth Group's Q4 2018 filing shows 45 new, 329 increased, 394 reduced and 141 closed positions. Its largest new stake was Linde: 887,743 shares worth $139M. The largest sale was Energy Transfer Partners, L.P., an estimated $425M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Energy.

  • CIBC Private Wealth Group's largest Q4 2018 buy was Linde: 887,743 shares worth $139M.
  • CIBC Private Wealth Group added most to Energy Transfer Partners in Q4 2018, an estimated $420M increase.
  • CIBC Private Wealth Group's biggest Q4 2018 reduction was American Tower, cutting an estimated $89.8M.
  • CIBC Private Wealth Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $425M.
  • CIBC Private Wealth Group's ten largest holdings make up 21% of its $22.4B portfolio in Q4 2018.
  • CIBC Private Wealth Group opened 45 new positions and closed 141 in Q4 2018.
  • CIBC Private Wealth Group's portfolio value fell 15% quarter-over-quarter to $22.4B.

Based on CIBC Private Wealth Group's 13F filing for Q4 2018, filed 5 Feb 2019.